Latest Insider Transactions at Bio Atla, Inc. (BCAB)
This section provides a real-time view of insider transactions for Bio Atla, Inc. (BCAB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BioAtla, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BioAtla, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Apr 30
2022
|
Richard A Waldron Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
970
-0.74%
|
$2,910
$3.48 P/Share
|
Mar 31
2022
|
Jay M Phd Short Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,888
-0.22%
|
$14,440
$5.0 P/Share
|
Mar 31
2022
|
Eric Sievers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
554
-0.62%
|
$2,770
$5.0 P/Share
|
Mar 31
2022
|
Scott Andrew Smith |
SELL
Payment of exercise price or tax liability
|
Direct |
1,791
-0.53%
|
$8,955
$5.0 P/Share
|
Mar 31
2022
|
Christian Vasquez Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
189
-0.75%
|
$945
$5.0 P/Share
|
Mar 31
2022
|
Richard A Waldron Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
970
-0.74%
|
$4,850
$5.0 P/Share
|
Feb 28
2022
|
Jay M Phd Short Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,888
-0.22%
|
$17,328
$6.48 P/Share
|
Feb 28
2022
|
Eric Sievers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
555
-0.62%
|
$3,330
$6.48 P/Share
|
Feb 28
2022
|
Scott Andrew Smith |
SELL
Payment of exercise price or tax liability
|
Direct |
1,791
-0.53%
|
$10,746
$6.48 P/Share
|
Feb 28
2022
|
Christian Vasquez Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
230
-0.91%
|
$1,380
$6.48 P/Share
|
Feb 28
2022
|
Richard A Waldron Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
970
-0.73%
|
$5,820
$6.48 P/Share
|
Jan 31
2022
|
Jay M Phd Short Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,378
-0.26%
|
$30,402
$9.56 P/Share
|
Jan 31
2022
|
Eric Sievers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
657
-0.72%
|
$5,913
$9.56 P/Share
|
Jan 31
2022
|
Scott Andrew Smith |
SELL
Payment of exercise price or tax liability
|
Direct |
2,181
-0.64%
|
$19,629
$9.56 P/Share
|
Jan 31
2022
|
Christian Vasquez Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
230
-0.9%
|
$2,070
$9.56 P/Share
|
Jan 31
2022
|
Richard A Waldron Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,150
-0.86%
|
$10,350
$9.56 P/Share
|
Dec 31
2021
|
Jay M Phd Short Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,667
-0.35%
|
$88,673
$19.63 P/Share
|
Dec 31
2021
|
Eric Sievers Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
795
-0.87%
|
$15,105
$19.63 P/Share
|
Dec 31
2021
|
Scott Andrew Smith |
SELL
Payment of exercise price or tax liability
|
Direct |
2,894
-0.84%
|
$54,986
$19.63 P/Share
|
Dec 31
2021
|
Christian Vasquez Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
194
-0.77%
|
$3,686
$19.63 P/Share
|
Dec 31
2021
|
Richard A Waldron Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,391
-1.03%
|
$26,429
$19.63 P/Share
|
Dec 02
2021
|
Jay M Phd Short Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,811
-0.18%
|
$105,842
$22.11 P/Share
|
Dec 02
2021
|
Eric Sievers Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
820
-0.44%
|
$18,040
$22.11 P/Share
|
Dec 02
2021
|
Scott Andrew Smith |
SELL
Open market or private sale
|
Direct |
2,984
-0.43%
|
$65,648
$22.11 P/Share
|
Dec 02
2021
|
Christian Vasquez Officer |
SELL
Open market or private sale
|
Direct |
200
-0.39%
|
$4,400
$22.11 P/Share
|
Dec 02
2021
|
Richard A Waldron Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,434
-0.53%
|
$31,548
$22.11 P/Share
|
Dec 01
2021
|
Jay M Phd Short Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
24,321
-0.6%
|
$559,383
$23.23 P/Share
|
Dec 01
2021
|
Eric Sievers Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
173
-0.06%
|
$3,979
$23.23 P/Share
|
Dec 01
2021
|
Scott Andrew Smith |
SELL
Open market or private sale
|
Direct |
628
-0.06%
|
$14,444
$23.23 P/Share
|
Dec 01
2021
|
Christian Vasquez Officer |
SELL
Open market or private sale
|
Direct |
1,011
-1.29%
|
$23,253
$23.23 P/Share
|
Dec 01
2021
|
Richard A Waldron Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,246
-1.71%
|
$166,658
$23.23 P/Share
|
Nov 30
2021
|
Jay M Phd Short Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,490
-0.45%
|
$443,760
$24.69 P/Share
|
Nov 30
2021
|
Eric Sievers Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
131
-0.05%
|
$3,144
$24.69 P/Share
|
Nov 30
2021
|
Scott Andrew Smith |
SELL
Open market or private sale
|
Direct |
478
-0.05%
|
$11,472
$24.69 P/Share
|
Nov 30
2021
|
Christian Vasquez Officer |
SELL
Open market or private sale
|
Direct |
768
-0.95%
|
$18,432
$24.69 P/Share
|
Nov 30
2021
|
Richard A Waldron Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,510
-1.25%
|
$132,240
$24.69 P/Share
|
Nov 29
2021
|
Jay M Phd Short Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,435
-1.12%
|
$355,005
$23.89 P/Share
|
Nov 29
2021
|
Eric Sievers Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
110
-0.12%
|
$2,530
$23.89 P/Share
|
Nov 29
2021
|
Scott Andrew Smith |
SELL
Open market or private sale
|
Direct |
399
-0.11%
|
$9,177
$23.89 P/Share
|
Nov 29
2021
|
Christian Vasquez Officer |
SELL
Open market or private sale
|
Direct |
642
-2.3%
|
$14,766
$23.89 P/Share
|
Nov 29
2021
|
Richard A Waldron Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,599
-3.0%
|
$105,777
$23.89 P/Share
|
Nov 24
2021
|
Jay M Phd Short Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
17,022
-0.41%
|
$408,528
$24.94 P/Share
|
Nov 24
2021
|
Eric Sievers Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
129
-0.05%
|
$3,096
$24.94 P/Share
|
Nov 24
2021
|
Scott Andrew Smith |
SELL
Open market or private sale
|
Direct |
466
-0.04%
|
$11,184
$24.94 P/Share
|
Nov 24
2021
|
Christian Vasquez Officer |
SELL
Open market or private sale
|
Direct |
750
-0.88%
|
$18,000
$24.94 P/Share
|
Nov 24
2021
|
Richard A Waldron Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,937
-0.84%
|
$94,488
$24.94 P/Share
|
Nov 23
2021
|
Jay M Phd Short Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
24,943
-0.88%
|
$623,575
$25.17 P/Share
|
Nov 23
2021
|
Eric Sievers Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
187
-0.1%
|
$4,675
$25.17 P/Share
|
Nov 23
2021
|
Scott Andrew Smith |
SELL
Open market or private sale
|
Direct |
684
-0.1%
|
$17,100
$25.17 P/Share
|
Nov 23
2021
|
Christian Vasquez Officer |
SELL
Open market or private sale
|
Direct |
1,100
-1.87%
|
$27,500
$25.17 P/Share
|